![Douglas B. Buchanan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas B. Buchanan
Président chez Abozymes Biomedical, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Norma Biln | F | - |
Augurex Life Sciences Corp.
![]() Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | 18 ans |
Barton Finlay | M | - |
Microbiome Insights, Inc.
![]() Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | 9 ans |
Malcolm C. Kendall | M | - |
Microbiome Insights, Inc.
![]() Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | 9 ans |
Bill Mohn | M | - |
Microbiome Insights, Inc.
![]() Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | 9 ans |
John Coleman | M | - |
Abozymes Biomedical, Inc.
![]() Abozymes Biomedical, Inc. Medical SpecialtiesHealth Technology Abozymes Biomedical, Inc. develops biotechnology for blood transfusions and organ transplant services. The CEO of the Canadian company is John Coleman. | - |
Pieter Cullis | M | - |
Microbiome Insights, Inc.
![]() Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | - |
David Demers | M | 68 |
Augurex Life Sciences Corp.
![]() Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | 6 ans |
Tim W.H. Chan | M | - |
Augurex Life Sciences Corp.
![]() Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | - |
Bradley Popovich | M | - |
Microbiome Insights, Inc.
![]() Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | - |
Natalie E. Dakers | F | - |
Augurex Life Sciences Corp.
![]() Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | - |
Mike Fannon | M | - |
Microbiome Insights, Inc.
![]() Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Paul A. Houston | M | 73 | 7 ans | |
Monika Russell | F | - | 10 ans | |
John Lacey | M | 80 | 7 ans | |
K. Gordon Green | M | - | 15 ans | |
Joseph J. Gurandiano | M | 78 | 2 ans | |
Robert A. Fairweather | M | - | 2 ans | |
Robert J. Chadwick | M | - | - | |
Jonathan I. Mishkin | M | - | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Canada | 19 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Douglas B. Buchanan
- Réseau Personnel